BIOTECanada responds to CDA-AMC's consultation on proposed improvements to the reimbursement review process

BIOTECanada welcomed the opportunity to comment on the CDA-AMC’s consultation on proposed improvements to the Reimbursement Review Process and recognized the significant progress and process innovation that CDA is making in these proposals which meaningfully reflect input provided by the association in the past. This includes increasing and improving HTA-manufacturer dialogue with new in-review meetings opportunities, incorporating rolling review processes, and expanding on some approaches to the deliberative framework.